164 related articles for article (PubMed ID: 9442980)
1. Cardiovascular toxicity with cancer chemotherapy.
Frishman WH; Sung HM; Yee HC; Liu LL; Keefe D; Einzig AI; Dutcher J
Curr Probl Cancer; 1997; 21(6):301-60. PubMed ID: 9442980
[No Abstract] [Full Text] [Related]
2. Cardiotoxicity and anthracyclines.
Stebbing J; Jones A; Barrett-Lee P
Breast Cancer Res Treat; 2008 Feb; 107(3):451-3. PubMed ID: 18167621
[No Abstract] [Full Text] [Related]
3. [Chemotherapy-induced cardiac toxicity and management].
Komagata H; Sakai H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular toxicity with cancer chemotherapy.
Frishman WH; Sung HM; Yee HC; Liu LL; Einzig AI; Dutcher J; Keefe D
Curr Probl Cardiol; 1996 Apr; 21(4):225-86. PubMed ID: 8697798
[No Abstract] [Full Text] [Related]
5. The heart of the matter.
Portera CC; Swain SM
J Clin Oncol; 2007 Sep; 25(25):3794-6. PubMed ID: 17664459
[No Abstract] [Full Text] [Related]
6. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?
Morris PG; Hudis CA
J Clin Oncol; 2010 Jul; 28(21):3407-10. PubMed ID: 20530269
[No Abstract] [Full Text] [Related]
8. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.
Gianni L; Salvatorelli E; Minotti G
Cardiovasc Toxicol; 2007; 7(2):67-71. PubMed ID: 17652806
[TBL] [Abstract][Full Text] [Related]
9. Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study.
Souza CA; Simões R; Borges KBG; Oliveira AN; Zogeib JB; Alves B; Malachias MVB; Drummond-Lage AP; Rezende BA
Arq Bras Cardiol; 2018 Nov; 111(5):721-728. PubMed ID: 30281690
[TBL] [Abstract][Full Text] [Related]
10. [Cardiac and vascular toxicity of chemotherapies].
Ederhy S; Ancedy Y; Champiat S; Lopez-Trabada-Ataz D; Dulery R; Cohen A
Rev Prat; 2018 Mar; 68(3):326-329. PubMed ID: 30869300
[TBL] [Abstract][Full Text] [Related]
11. The cardiotoxicity of anticancer agents.
Von Hoff DD; Rozencweig M; Piccart M
Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608
[TBL] [Abstract][Full Text] [Related]
12. [Heart failure in a subject treated with anthracyclines in childhood: myocardial dysfunction is not always the only reason of it].
Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15346697
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity of doxorubicin and other anthracycline derivatives.
Jain D
J Nucl Cardiol; 2000; 7(1):53-62. PubMed ID: 10698235
[No Abstract] [Full Text] [Related]
14. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
Safonova SA; Gershanovich ML; Punanov IuA
Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373
[No Abstract] [Full Text] [Related]
15. Cardiac safety of liposomal anthracyclines.
Batist G
Cardiovasc Toxicol; 2007; 7(2):72-4. PubMed ID: 17652807
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
Bristow MR; Billingham ME; Mason JW; Daniels JR
Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
[TBL] [Abstract][Full Text] [Related]
17. Heart failure in a breast cancer survivor.
Moore S
Oncol Nurs Forum; 2012 Mar; 39(2):147-50. PubMed ID: 22374488
[No Abstract] [Full Text] [Related]
18. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
[TBL] [Abstract][Full Text] [Related]
19. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
Gramatyka M
Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
[TBL] [Abstract][Full Text] [Related]
20. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.
Wiseman LR; Spencer CM
Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
